ALZPro® | Alzheimer's Association® ALZPro® is your central hub offering the latest clinical guidelines, education and training, research publications and practical tools for researchers, clinicians and dementia care providers.

For additional clinical aids, explore ALZPro and sign up to be notified whenever new content is released.
alz.org/ALZPro

#ENDALZ #BrainHealth #ClinicalCare #DementiaRiskReduction #EndAlzheimers

The @alzassociation.bsky.social is leading the effort to turn dementia science into clinical action, equipping providers and their teams with evidence-informed tools and guidance to support patients and their care partners at every stage.

ALZPro® | Alzheimer's Association® ALZPro® is your central hub offering the latest clinical guidelines, education and training, research publications and practical tools for researchers, clinicians and dementia care providers.

Today is END ALZ Day – a call to move evidence into everyday care.

For clinicians, that means applying what research shows: addressing physical activity, nutrition, cognitive and social engagement, and overall well‑being can meaningfully reduce the risk of cognitive decline.

10 Healthy Habits for Your Brain Learn about healthy actions you can take for your brain that can lower the risk of cognitive decline and possibly dementia.

Tomorrow is END ALZ Day – a moment to turn evidence into action. Clinicians can help patients understand how everyday behaviors can support brain health, & the Alzheimer’s Association’s 10 Healthy Habits for Your Brain guides brain health for individuals & families. Learn more: alz.org/HealthyHabits

Dementia Care Provider Roundtable | Alzheimer's Association The AADCPR is advancing care and support services for people with Alzheimer’s and other dementias and their caregivers – learn about its nationwide impact.

The Roundtable is a noncompetitive consortium designed for leaders who want to stay ahead of the science, exchange real-world strategies and help shape the future of dementia care.

If this work resonates with you, consider joining the Roundtable: www.alz.org/professional...

The discussion included:

• Updates on blood-based biomarkers and the U.S. POINTER study from Courtney Kloske, Ph.D.

• Brain health strategies, including the MIND diet, from Maggie Moon, MS, RD

• Peer exchange on advancing quality dementia care across diverse care settings

The meeting brought together organizations from across assisted living, nursing homes and home- and community-based services to share what’s working—and what’s next. The discussion spanned both emerging science and practical application.

Bringing leaders together to shape the future of dementia care is how real progress happens.

In March, the Dementia Care Provider Roundtable held its first in-person meeting of 2026.

Explore the latest issue of #TRCI for key takeaways from the spring 2025 @alzassociation.bsky.social Research Roundtable on advances in biomarkers, prevention & treatment approaches before cognitive symptoms. #AlzSky

Learn More: alz-journals.onlinelibrary.wiley.com/doi/10.1002/...

Alzheimer’s Association Looks Ahead to a New Era: Early Detection and Prevention of Cognitive Decline The Alzheimer's Association is leading a pivotal shift in early detection and treatment: identifying risk factors, accurate diagnosis & earlier intervention.

Earlier detection of AD is advancing.
A recent @alzassociation.bsky.social Research Roundtable explored how biomarkers, emerging therapies & health system readiness could support identifying & addressing Alzheimer’s before symptoms begin: www.alz.org/news/2026/ne...
@alzdemjournals.bsky.social #TRCI

#AAIC26 is a hub of scientific energy — and a catalyst for progress — uniting the world’s brightest minds in Alzheimer’s and dementia science and clinical practice. Take advantage of early-bird registration prices now until May 15: alz.org/aaic.

Q&A: U.S. POINTER Trial Data Show Structured Lifestyle Changes Extend Benefits Beyond Cognition | www.PhysiciansWeekly.com Q&A highlights how U.S. POINTER lifestyle interventions improved cognition and cardiometabolic health.

Heather M. Snyder, Ph.D., @alzassociation.bsky.social senior vice president of Medical & Scientific Relations, talks with Physicians Weekly about the U.S. POINTER lifestyle intervention and how sticking to a structure brings clinically meaningful benefits. www.physiciansweekly.com/post/qa-u-s-...

“Brain health and dementia care require a team approach—and now we can train those teams together using the highest national standards.” -Katie Evans, chief programs and mission engagement officer, Alzheimer’s Association.

We’ve earned Joint Accreditation for Interprofessional Continuing Education, enabling training for entire health care teams through a unified process—advancing brain health, early detection and high-quality dementia care nationwide. bit.ly/44ZX4L9

#BrainHealth #DementiaCare #HealthCareQuality

Research of the Year 2025 This Medical News article is an editor’s choice roundup of the most impactful, newsworthy, and novel studies published in JAMA over the past year.

Results from @alzassociation.bsky.social’s U.S. POINTER lifestyle intervention trial were named to @jama.com’s Research of the Year roundup—recognizing its rigor and relevance for clinicians and health systems advancing evidence-based dementia risk reduction. #JAMAROTY25 ja.ma/4j3tdar

Researchers and clinicians can now request access to ALZ-NET data to support further research + real-time, high-level data is publicly accessible via the ALZ-NET Data Dashboard. Explore how real-world data is shaping Alzheimer’s care: alz-net.org/datarequest

First ALZ-NET Data Readout Marks Milestone in Building Real-World Evidence for Alzheimer’s Treatment New clinical & imaging data reported at CTAD shows anti-amyloid drugs have similar safety & efficacy in real-world settings to tightly controlled clinical trials.

New real-world data from ALZ-NET shared for the first time at #CTAD25 shows outcomes on FDA-approved anti-amyloid therapies are consistent with clinical trials, with stable cognition/function and expected ARIA rates. Learn more: www.alz.org/news/2025/al...

“These studies tell us that the U.S. POINTER lifestyle intervention with structured support has substantial and significant health benefits in areas known to lower risk of cognitive decline and dementia." Maria C. Carrillo, Ph.D., Alzheimer’s Association chief science officer and medical affairs [Alzheimer's Association logo]

Three add-on studies find U.S. POINTER lifestyle intervention improved blood pressure regulation of blood flow to the brain, reduced sleep apnea respiratory events & increased cognitive resilience for adults with certain Alzheimer’s-related brain changes. bit.ly/3MiCTBy

Alzheimer’s Association Statement on Oral Semaglutide Phase 3 Topline Data Release Clinical trials testing an oral semaglutide pill for the treatment of early Alzheimer’s disease did not meet their primary endpoints.

The evoke & evoke+ clinical trials testing an oral semaglutide pill to treat early Alzheimer’s did not demonstrate a statistically significant reduction in disease progression. 

While we’re disappointed in the results, these studies provide valuable insights to guide future research. bit.ly/3M0OTaH

Alzheimer’s Association Welcomes FDA Clearance of First Blood Test for Use in Primary Care to Rule Out Alzheimer’s-Related Amyloid Pathology Developed by Roche, this is the first blood test for use in primary care to rule out Alzheimer's-related amyloid pathology.

The FDA has cleared the first blood test for Alzheimer’s for use in primary care settings to rule out the presence of amyloid.

“This is another important step toward expanding access to Alzheimer’s diagnostic tools."-Joanne Pike, Association president & CEO

Read our full statement: bit.ly/4oh3Tiu.

We're Exhibiting AAFP FMX25 Anaheim - October 5-9 LET'S CONNECT AT FMX Alzheimer's Association ALZPro at the Alzheimer's Association Booth: 857

🚨 Headed to #AAFPFMX in Anaheim (Oct 5–9)? Come find us at Booth 857! 🎉

We’ll be sharing how ALZPro + the Alzheimer’s Association support family physicians with evidence-based tools and resources for frontline care.

👉 Details + registration: i.snoball.it/p/JLpaJ/l/1

Calling all health care professionals: your new go-to resource is here. 🩺📚

ALZPro gives you centralized access to the latest science and practice tools—from clinical guidelines to continuing education to care pathways and more.

Learn more: alz.org/ALZPro

ALZPro was created to empower professionals like you to reduce risk, advance early detection, improve care and expand equitable access.

Explore this new resource from @alzassociation.bsky.social to stay ahead in the fast-changing landscape of dementia care.

Learn more: alz.org/ALZPro

ALZPro™ | Alzheimer's Association® ALZPro™ is your central hub offering the latest clinical guidelines, education and training, research publications and practical tools for researchers, clinicians and dementia care providers.

Care professionals: Navigate care with confidence. From care planning and risk reduction to navigation and caregiver support, ALZPro helps you deliver high-quality, compassionate services across settings and stages.
Learn more: alz.org/alzpro
#DementiaCare

ALZPro™ | Alzheimer's Association® ALZPro™ is your central hub offering the latest clinical guidelines, education and training, research publications and practical tools for researchers, clinicians and dementia care providers.

Health care professionals: thank you for attending AAIC For All to hear the latest in Alzheimer’s treatment, prevention & care.

➡️ Next up: Explore ALZPro—the Association’s new hub that centralizes the tools you need. alz.org/ALZPro

#AAIC25 @alzpro.bsky.social

Alzheimer's Association ALZPro Empowering Professionals in the Fight Against Dementia

Health care professionals: ALZPro is your gateway to the latest science and practice resources from @alzassociation.bsky.social. Whether you're providing care, conducting research, or building better systems, ALZPro helps you stay informed and connected.
alz.org/ALZPro

#AAIC25 #ALZsky

A CGI rendering of neurons. They are purple on a white background.

Researchers: Accelerate discovery & grow your impact.

ALZPro is a new centralized hub from @alzassociation.bsky.social connecting you with funding opportunities, publication channels, data tools, and research networks to advance dementia science.

Learn more: alz.org/alzpro
#AAIC25 #ALZSky

Two Alzheimer's Association staff stand behind the ALZPro booth and smile at the camera. They are both wearing purple #ENDALZ sunglasses.

#AAIC25 attendees: Want more info on ALZPro? Visit our team at Booth 1010 in the Exhibit Hall to discover how this new professional hub offers essential resources, and follow @alzpro.bsky.social for future updates.

Welcome to ALZPro | Alzheimer's Association® ALZPro is your centralized platform offering the latest clinical guidelines, education and training, research publications and practical tools for researchers, clinicians and dementia care providers.

Meet ALZPro.

Health care professionals & researchers, this centralized hub from the @alzassociation.bsky.social is your single point of access for the latest science and practice tools. Stay current, connect with peers, and deliver better care.

➡️Start exploring: alz.org/alzpro